In Asia Pacific, countries like China, Japan, and South Korea are likely to witness a surge in demand for pruritus therapeutics due to the rising geriatric population, increasing awareness about skin disorders, and advancements in healthcare technology. China is expected to hold the largest market share in this region, followed by Japan and South Korea.
Europe, particularly the United Kingdom, Germany, and France, is also expected to witness considerable growth in the pruritus therapeutics market. Factors such as the high prevalence of skin disorders, increasing healthcare expenditure, and availability of advanced treatment options are likely to drive market growth in these countries. Germany is anticipated to lead the market in Europe, followed by the United Kingdom and France.